Evidence map›Paper›PMID 10698501›Full record

ArticleOncogene2000

Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein.

A Kaida, Y Ariumi, Y Ueda, J Y Lin, M Hijikata, S Ikawa, K Shimotohno

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. HIV-1 Vpr and p21 restrict LINE-1 mobility.Nucleic acids research · 2018
    Article
  4. Review
  5. Oncogenes and RNA splicing of human tumor viruses.Emerging microbes & infections · 2014
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. T-cell control by human T-cell leukemia/lymphoma virus type 1.International journal of hematology · 2003
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

A KaidaDepartment of Viral Oncology, Institute for Virus Research, Kyoto University, Japan.
Y Ariumi
Y Ueda
J Y Lin
M Hijikata
S Ikawa
K Shimotohno
Kyoto University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have previously demonstrated that the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein represses the trans-activation function of p53 tumor suppressor protein. Recently, several proteins with sequence homology to p53 have been identified. In this study, we demonstrated that Tax represses the trans-activation functions of p73alpha, p73beta, and p51A, the p53-related proteins, as well as p53. Moreover, a mutant Tax of coactivator CBP-binding site (K88A), which activated NF-kappaB but not CREB pathway, could not repress the p73 nor p51 trans-activation functions, indicating that CBP-binding domain of Tax is essential for the suppression of their functions. Using proteins of Gal4-fused N-terminal region of p73 and p51, we showed that Tax-mediated inactivation of p73 or p51 requires for their N-terminal trans-activation domains. Furthermore, only the putative N-terminal trans-activation domains of them did not have enough transcriptional activities and their adjacent regions are essential for their full trans-activation, suggesting the existence of their second trans-activation subdomains. Thus, HTLV-1 Tax inactivated the p53-related proteins through their N-terminal trans-activation domains.

Indexed as

Gene Expression Regulation, ViralPhosphoproteinsTrans-ActivatorsDNA-Binding ProteinsGene Products, taxGenes, pXGenes, Tumor SuppressorHumansHuman T-lymphotropic virus 1Nuclear ProteinsProtein Structure, TertiaryRecombinant Fusion ProteinsStructure-Activity RelationshipT-LymphocytesTranscriptional ActivationTranscription FactorsDNA-Binding ProteinsGene Products, taxNuclear ProteinsPhosphoproteinsRecombinant Fusion ProteinsTP63 protein, humanTP73 protein, humanTrans-ActivatorsTranscription FactorsTumor Protein p73Tumor Suppressor Proteins

Identifiers

PMID10698501
OpenAlexW2325641799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.